Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 5,015,034
  • Shares Outstanding, K 47,590
  • Annual Sales, $ 1,681 M
  • Annual Income, $ 154,770 K
  • 36-Month Beta 0.99
  • Price/Sales 2.99
  • Price/Cash Flow 14.37
  • Price/Book 5.22

Price Performance

See More
Period Period Low Period High Performance
1-Month
103.42 +2.02%
on 08/23/17
109.59 -3.72%
on 09/08/17
+1.53 (+1.47%)
since 08/22/17
3-Month
94.15 +12.07%
on 08/09/17
109.59 -3.72%
on 09/08/17
+5.10 (+5.08%)
since 06/22/17
52-Week
67.20 +57.01%
on 11/03/16
109.59 -3.72%
on 09/08/17
+22.55 (+27.18%)
since 09/22/16

Most Recent Stories

More News
Charles River Research Models in Drug Discovery Award Presented to Sonia Vallabh and Eric Minikel of the Prion Alliance

On Tuesday, September 26, 2017, James Foster, Chairman, President and Chief Executive Officer of Charles River Laboratories International, Inc. will present the first Charles River Research...

CRL : 105.51 (+0.12%)
Charles River Laboratories to Present at September Investor Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including:

WFC : 54.25 (+0.35%)
CRL : 105.51 (+0.12%)
Best Relative Performance in the Life Sciences Tools & Services Industry Detected in Shares of Neogenomics Inc (NEO, ILMN, TMO, CRL, QGEN)

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

ILMN : 201.41 (+0.58%)
TMO : 188.30 (+0.21%)
NEO : 11.01 (+0.82%)
QGEN : 32.19 (+1.00%)
CRL : 105.51 (+0.12%)
Shares of Cambrex Corp Rank the Highest in Terms of Relative Performance in the Life Sciences Tools & Services Industry (CBM, TMO, INCR, PRAH, CRL)

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

INCR : 52.00 (+0.29%)
TMO : 188.30 (+0.21%)
PRAH : 75.09 (-0.78%)
CRL : 105.51 (+0.12%)
CBM : 54.05 (+1.12%)
Distinguished Industry Leaders Join Lineup for Inaugural Charles River World Congress on Animal Models in Drug Discovery & Development

Charles River Laboratories International, Inc. is proud to host the Inaugural Charles River World Congress on Animal Models in Drug Discovery & Development. Ranging from academia to the commercial...

CRL : 105.51 (+0.12%)
Best Relative Performance in the Life Sciences Tools & Services Industry Detected in Shares of Illumina Inc (ILMN, INCR, A, CRL, TMO)

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

A : 65.78 (-0.21%)
ILMN : 201.41 (+0.58%)
INCR : 52.00 (+0.29%)
TMO : 188.30 (+0.21%)
CRL : 105.51 (+0.12%)
Quintiles Ims Ho is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (Q, BRKR, CRL, PKI, QGEN)

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

Q : 94.70 (+0.51%)
BRKR : 29.36 (-0.20%)
QGEN : 32.19 (+1.00%)
CRL : 105.51 (+0.12%)
PKI : 68.17 (-0.04%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (INCR, A, CRL, VWR, PRXL)

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

VWR : 33.16 (+0.09%)
A : 65.78 (-0.21%)
PRXL : 87.99 (-0.01%)
INCR : 52.00 (+0.29%)
CRL : 105.51 (+0.12%)
Charles River Laboratories International Reaches Analyst Target Price

In recent trading, shares of Charles River Laboratories International Inc. have crossed above the average analyst 12-month target price of $99.45, changing hands for $99.71/share.

CRL : 105.51 (+0.12%)
Accelerate Diagn is Among the Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (AXDX, CRL, INCR, PRAH, QGEN)

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

AXDX : 22.70 (-1.30%)
INCR : 52.00 (+0.29%)
QGEN : 32.19 (+1.00%)
CRL : 105.51 (+0.12%)
PRAH : 75.09 (-0.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Charles River Laboratories is a leading provider of critical research tools and integrated support services that enable innovative and efficient drug discovery and development. Charles River is the global leader inproviding the animal research models required in research and development for new drugs,...

See More

Support & Resistance

2nd Resistance Point 106.74
1st Resistance Point 106.13
Last Price 105.51
1st Support Level 104.60
2nd Support Level 103.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.